Garware Marine Industries Limited (BOM:509563)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	146	161	61	35	67	27
Market Cap Growth	163.43%	163.43%	76.83%	-48.54%	153.48%	107.21%
Enterprise Value	146	161	61	34	66	22
Last Close Price	25.31	27.95	10.61	6.00	11.66	4.60
PE Ratio	33.75	37.36	-	29.88	470.17	18.69
PS Ratio	12.12	13.38	8.59	2.83	4.25	2.04
PB Ratio	0.81	0.90	0.55	0.44	0.60	0.46
P/TBV Ratio	0.81	0.90	0.55	0.44	0.60	0.46
P/FCF Ratio	-	-	-	-	75.46	11.91
P/OCF Ratio	16215.79	17907.21	-	-	69.60	11.91
EV/Sales Ratio	12.10	13.37	8.58	2.78	4.16	1.72
EV/EBITDA Ratio	33.35	36.86	-	28.62	450.77	15.22
EV/EBIT Ratio	33.50	37.02	-	29.23	473.47	15.33
EV/FCF Ratio	-2206.88	-	-	-	73.86	10.05
Asset Turnover	0.08	0.08	0.07	0.12	0.18	0.21
Quick Ratio	13.74	13.74	11.62	14.92	21.32	25.01
Current Ratio	13.76	13.76	12.51	16.08	23.04	26.82
Return on Equity (ROE)	2.97%	2.97%	-0.72%	1.21%	0.17%	2.63%
Return on Assets (ROA)	1.77%	1.77%	-0.41%	0.74%	0.10%	1.50%
Return on Capital (ROIC)	1.87%	1.87%	-0.42%	0.76%	0.10%	1.69%
Return on Capital Employed (ROCE)	2.30%	2.30%	-	1.50%	0.10%	2.30%
Earnings Yield	2.96%	2.68%	-1.11%	3.35%	0.21%	5.35%
FCF Yield	-0.05%	-0.04%	-0.36%	-2.39%	1.32%	8.40%
Buyback Yield / Dilution	0.25%	0.25%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.